Physician profile
Edward Martinez
NPI 1750893756
$830.20
in general payments reported to CMS, 2019-2025
12 companies · $461 in 2025
The $461 reported for 2025 was more than what 78% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $101 · 2023: $57.97 · 2024: $211 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $243.30 | 2024-2025 | Durolane |
| Zimmer Biomet Holdings, INC. | $140.05 | 2024-2025 | Persona |
| Stryker Corporation | $85.92 | 2022 | |
| Orthalign INC | $72.42 | 2024 | Orthalign Plus |
| Astrazeneca Pharmaceuticals LP | $70.45 | 2024-2025 | Airsupra |
| Ferring Pharmaceuticals INC. | $62.17 | 2023-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $48.46 | 2022-2025 | Monovisc, Orthovisc |
| Smith+Nephew, INC. | $29.54 | 2025 | Bone Anchors With Arthroscopic Delivery System |
| Antares Pharma, INC. | $23.45 | 2023 | Tlando, Xyosted, Nocdurna |
| Kerecis Limited | $19.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Davol INC. | $17.71 | 2025 | Arista |
| Cipher Pharmaceuticals US LLC | $16.83 | 2025 | Spinosad, Natroba |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.